| Bioactivity | Angiogenin (108-122) TFA is an angiogenin peptide. | ||||||
| Invitro | Angiogenin (108-122) effects on the ribonucleolytic activity of angiogenin using tRNA as substrate with 39% inhibition[1]. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease[2]. | ||||||
| Name | Angiogenin (108-122) (TFA) | ||||||
| Sequence | Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg | ||||||
| Shortening | ENGLPVHLDQSIFRR | ||||||
| Formula | C80H126F3N25O25 | ||||||
| Molar Mass | 1895.00 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |